Development of automated analytical capability for the early detection of diabetes mellitus by Zlatkis, A.
General Disclaimer 
One or more of the Following Statements may affect this Document 
 
 This document has been reproduced from the best copy furnished by the 
organizational source. It is being released in the interest of making available as 
much information as possible. 
 
 This document may contain data, which exceeds the sheet parameters. It was 
furnished in this condition by the organizational source and is the best copy 
available. 
 
 This document may contain tone-on-tone or color graphs, charts and/or pictures, 
which have been reproduced in black and white. 
 
 This document is paginated as submitted by the original source. 
 
 Portions of this document are not fully legible due to the historical nature of some 
of the material. However, it is the best reproduction available from the original 
submission. 
 
 
 
 
 
 
 
Produced by the NASA Center for Aerospace Information (CASI) 
https://ntrs.nasa.gov/search.jsp?R=19770010756 2020-03-22T10:36:22+00:00Z
NAS 9-14534
DEVELOPMENT OF AUTOMATED ANALYTICAL
CAPABILI'I •Y FOR THE EARLY DETECTION OF
DIABETES MELLITUS
(2+ASA'^:-l^lc.r)	 ELVf1C1MPNT C1 AUTCMAIFC 	 177-177.0
t,..ALY1LC;L C.AEAL1Lt.Y FCF 1ht BAb1Y
LL:bCI—ILL L` Llbrcit^ MILLI':US F1aai FEFCLt
(HOU:tou i1c.iV.)	 cl E hC A^21CF W CJCL Obt	 UuCias63/52 1bi^8
Final Report
May, 1976
	
s
I
,..
Dr. Albert 7.latkis
Chemistry Departnent
University of Houston
Houston, Texas 77004
Rf,R 7
RECrI v p
NAS,j srr F
INPLI f 6,RA. HPrincipal Investib: 	 • :
TABLE OF CONTENTS
Page
SUMMARY
1. ASPECTS OF DIABETES MELLITUS
1.1	 Pithophysiological abnormalities
1.2	 Acute decompensations
1.3	 Vascular complications
1.4	 Stages of diabetes mellitus
1.5	 Classification of overt diabetes mellitus
1.6	 Diagnosis of diabetes mellitus
2. STATEMENT OF THE PROBLEM
3. ANALYTICAL TECHNIQUES
3.1
	
Sample preparation
3.2	 Gas chromatographic separation
3.3	 Mass spectrometric identification
3.4	 Mass fragmentography
4. RESULTS AND DISCUSSION
4.1
	 Profiles of volatile metabolites in normal
urine.
4.2
	 Profiles of volatile metabolites in urine
of patients with diabetes mellitus
5. ki',iTRENCES
a1. ASPECTS OF DIABETES MELLITUS
1.1 Pathophys io logical abnormalities
Diabetes mellitus is a metabolic disorder characterized by a
deficiency of effective insulin. The deficiency may be caused by
a reduced secretion of insulin by the beta cells of the pancreas,
by tissue resistance to insulin or by other factors cawing insuffi-
r,
cient action of insulin.
As a consequence the blood glucose level is increased (hyper-
glycemia caused by reduced metabolism of glucose and increased
gluconeogenesis) and glucose is excreted in urine (glucosuria in
conjunction with polyuria, because glucose is not sufficiently
reabsorbed by the renal tubules).
Furthermore, insufficient insulin activity causes increased
.lipolysis resulting in high concentration of free fatty acids in
blood. The triglyceride synthesis is reduced. The excess of free
fatty acids and of acetyl - Co A leads to the formation of the ketone
bodies ^-hydroxybutyrate, acetoacetate and acetone. Their concen-
tration is increased in blood and they are excreted in urine.
A third consequence is an insufficient protein synthesis and
an increased metabolism of proteins.
1.2 Acute decompensations
Three forms of acute decompensation require immediate interven-
e	 tion	 ketoacidotic, hyperosmolar and hypoglycemic situations.
Under severe conditions the patient falls into coma.
llyperglycemia can lead to diabetic ketoacidosis. As a result
of the excess of free fatty acids and because of reduced utilization
of acetyl-Co A the synthesis of acetoacetic acid and ^ -hydroxy-
butyric acid is accelerated causing an increase of hydrogen ions.
During ketoacidosis the pH may drop to below 7.0 . Acetone is high
in serum, in urine and in breath. The blood glucose levels are
between 400 and 700 mg/100 ml.
Whereas ketoacidotic coma occurs mostly in patients with insulin
deficiency diabetes (juvenile diabetes) another form of hyperglycemic
coma, the hyperosmolar coma, occurs iri patients with adult diabetes.
With blood glucose levels of sometimes more than 1000 mg/100 ml and
without acidosis heavy glucosuria occurs. Osmotic diuresis causes
the loss of body water.
The decompensation of the blood glucose level in form of hypo-
glycemia may be caused by therapy: changed insulin. requirement or
error in insulin dose.
1.3 Vascular complications
Vascular diseases occur as chronic diabetic complications. They
affect kidneys, eyes, heart, central and peripheral nervous system
and appear as microangiopathy, nephropathy, retinopathy, atherosclerosis,
neuropathy or polyneuropathy. Pathogenesis and cause of these diabetic
complications are still controversial.
1.4 Stages of diabetes mellitus
(a) Prediabetes: It is the period between conception and first
manifestation of diabetes and is usually determined retrospectively.
During this period fasting blood glucose level and glucose
tolerance test are normal and no symptoms are observed.
Normally the identical twin of a diabetic patient and 'children
of two diabetic parents are classified as prediabetic.
(b) Latent diabetes: The patients have normal fasting blood
glucose and under standard conditions normal glucose tolerance.
Under stress conditions (infection, pregnancy, periods of
overweight) they develop pathological glucose tolerance.
(c) Asymptomatic (subclinical or chemical) diabetes: These
patients have normal or slightly" elevated fasting blood glucose
but abnormal glucose tolerance under standard conditions.
Except reactive hypoglycemia only occasional symptoms are
observed.
(d) overt diabetes: Tasting blood glucose and glucose tolerance
test are abnormal. Clucosuria, polyuria, ketonemia and ketonuria
are common.
1.5 Classification of overt diabetes mellitus
(a) Infantile diabetes: first manifestation and diagnosis
between 0 and 14 years of age. In most cases the patients
develop an abrupt onset, severe symptoms and depend on insulin.
(b) Juvenile diabetes,: first manifestation between 15 and
24 years of age. Usually acute symptoms occur and the patients
depend on insulin.
(c)! Adult- diabetes: first manifestation after 25 years of age.
Often the patients do not depend on insulin but can be treated
by diet or by oral antidiabetic medication.
1.6	 Diagnosis of diabetes mellitus
Overt diabetes mellitus is usually recognized by elevated
blood glucose levels and by glucosuria.
	
Fasting blood glucose
levels of ^!!2 140 mg/100 m1 in capillary blood or '^!! 130 mg/100 ml
In venous blood indicate diabetes mellitus.
	
The values depend r
somewhat on the method applied for determination.
Hexokinase-method, glucose oxidase-method and glucose
dehydrogenase-method are most frequently used.
Less severe cases of diabetes, borderline cases and latent
diabetes are diagnosed by tolerance tests.	 Commonly, the oral
glucose tolerance test and the intravenous glucose tolerance test
are applied.
Oral glucose tolerance test: 	 after drawing blood for deter-
mination of the fasting blood glucose concentration the patient is
given 100 g of glucose in 400 ml of water or tea. 	 Blood is taken
in definite intervals, e.g. after 30, 60, 90 and 120 minutes.
Normal values:	 maximum glucose level < 160 mg/100 ml; 2-h glucose
level < 120 mg/100 ml.
	
Clearly pathological values: 	 maximum
`t
glucose level	 > 180mg/100 ml, 2-h glucose level *;P140 mg/100 ml.
Intravenous glucose tolerance test:	 the patient is adminis-
tered a solution of 25 g of glucose or 0.5 - 0.8 g of glucose per
kg body-weight.	 The blood glucose is determined under fasting t
conditions and then every 10 minutes over a period of 80 minutes.
The mean glucose elimination in percent per minute (K-rate) is
j
°-': 1.2 for normal persons. 	 K G 1.0 indicates diabetes.
'
e
s
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2. STATEMENT OF THE PROBLEM
By ketogenesis the ketone bodies R -hydroxybutyrate, acetoacetate
and acetone are formed from acetyl-CoA. Acetone has been long known to
occur in urine of patients with diabetes mellitus. Its qualitative and
semiquantitative determination beloftgs to the routine controls of
diabetics, and very simple and rapid tests are available. Acetone is a
normal metabolite and is excreted in urine of every individual. In
urine of diabetics its concentration may be increasing by the factor of
100 or even more.
The goal of this investigation was to study the total profile of
volatile metabolites in urine of patients with diabetes mellitus. Be-
cause of the drastic abnormalities in the metabolism of carbohydrates,
lipids and proteins connected with diabetes we expected that apart from
acetone further characteristic abnormalities occur in the profiles of
volatile urinary metabolites in case of diabetes mellitus. We found
quantitative and qualitative changes in these urines as compared to the
urines of normal subjects.
3. ANALYTICAL TECHNIQUES
3.1 Sample preparation
For profile analyses the constituents have to be enriched.
Our first approach was a contin;aous extraction of 450, ml of a 24-h
urine with 80 ml of ether followed by distillation of the extract
at low temperature and under reduced pressure (1). The disadvantage
of this procedure is the possibility of introducing contaminants
t
sampling time:
extracting gas:
water condenser bet,
and adsorbent tubes
adsorbing material:
adsorbent tubes:
I 
helium, 20 ml/min.'
aeen sampling flask
12°C
Tenax GC,.35 - 60 mesh, 2 cm 
2 tubes in parallel, 11 cm x 10 mm O.D.
The optimization of sampling temperature, sampling time and water
bath temperature is described in (11).
3.2 Gas chromatographic separation -
After adsorption of the volatile compounds one adsorbent tube
was used for gas chromatographic separation. It was inserted into
the injector block of the gas chromatograph whose dimensions were
designed to accept the trap. In the injector block the substances
were desorbed and re-condensed in a pre-column cooled with liquid
air. After recondensation pre-column and separation column were
connected and the gas chromatographic separation was performed.
gas chromatograph:	 Model 900, Perkin-Eimer
integrator:	 Model 480, Varian Aerograph
column:	 100 m x 0.5 mm I.D., coated with
Emulphor ON-870 (polyoxyethylated fatty
alcohol), Supelco, Bellefonte, Pa.
pre-column:	 - 1 m x 0.75 mm I.D., coated with Emulphor ON-870.
column temperature: 	 60°C for 16 min, then programmed to
175% at 2°C/min
0u	 f
h
carrier gas:	 N21 at 5 ml/min
attenuation:	 256
detector:
	
YID
desorption:	 300°C, 15 ml N2 /min for 10 min
Comparisons of several desorption temperatures are described
in (11).
3.3 Mass spectrometric identification
The second adsorbent trap was used for mass spectrometric
identification and for mass fragmentography. The mass spectrometer
was coupled with the gas chromatograph (GC-MS combination) over a
platinum column of 30 cm in length. The total effluent from the
GC column entered the ion source of the mass spectrometer. No
separator was applied.
The mass spectrometer was connected on-line with a computer
for data acquisition and data processing. Mass spectra were recorded
exponentially at a scan rate of 2.5 sec/decade applying automatic
repetitive scanning. One spectrum was recorded approximately every
7 sec. All spectra were recorded on magnetic tape and were processed
after the analysis was completed. Calibration, background subtraction,
GC-peak subtraction, calculation of mean values of intensities from
several mass spectra and various other operations were performed to
facilitate the identification of the substances. The total ion
current of a second ion source (total pressure monitoring source) was
the signal for the gas chroma.togram. The following mass spectrometric
conditions were chosen t
a
electron energy of ion source 70 eV
electron energy of total pressure
monitoring source 20 eV
emission current 100 uA
accelerating voltage 3 kV
multiplier voltage 2 kV
ion source temperature 220°C
interface temperature 220°C
resolution 750
operation pressure 4.10-5 torr
3.4 Mass fragmentography
From the mass spectrometric data on magnetic tape computer
reproductions of the full chromatogram were obtained by plotting
the sum of the intensities of all ions. By selecting a specific
ion selective chromatograms of groups of compounds or of a single
compound were plotted. This selective detection of compounds by
computer-produced mass fragmentograms was described for primary
alcohols, ketones and sulfur compounds (10, 12).
4.	 RESULTS AND DISCUSSION
4.1 Profiles of volatile metabolites in normal urine
Combining the adsorption technique for concentration of the
compounds, thermal desorption and gas chromatography for their
separation, mass spectrometry for their identification and computer-
ized mass-fragmentography for their selective detection a powerful
fl
a
analytical system is available to study the profiles of low molecular
weight volatile substances and to analyze pathological variations in
these profiles.
The analysis of several hundred normal urines showed that a
large number of volatile substances (approximately 250 were counted
in the chromatograms) are found in urine. Their molecular weights
range from 40 to approximately 160 and their concentrations vary
widely. They are ketones, alcohols, aldehydes, sulfides, allyl
isothiocyanates, pyrroles, furan derivatives and pyrazines. A list
of the substances identified by mass spectrometry is given in Table I.
As key components in the profiles we found ketones with three
to nine carbon atoms. The concentrations of the constituents in the
profile are subject to physiological variations which are very pro-
nounced for some compounds, e.g, allyl isothiocyanate and carvone.
These compounds appear as large peaks in some profiles, whereas in
others they are completely absent. The dependence on the diet- is
not yet clearly established. Despite these variations we can ch-Arac-
terize a normal profile. Figure 1 is an example of a normal urinary
profile (28-year old male person), which was run at high attenuation.
Only substances of high concentration are detected resulting in a
simple and interpretable profile. The major components are :
1= acetone, 2= 2-butanone, 3= ethanol, 5= 2-pentanone, 7= dimethyl
disulfide, 9 = N-methylpyrrole, 10 = 3-penten-2-one, 12 = 4-heptanone,
14 = 2-heptanone, 17 - pyrrole. In this profile no allyl isothio-
cynnate and carvone are present. The person, participating in the
xscreening study were healthy individuals age 20 to 70 years, male
and female.	 They were allowed to follow their normal eatl.ig habits
except to avoid alcoholic beverages.
	
Exogenous ethanol is partially
excreted in urine and appears as a high peak.
	 It was observed that
intraindividual variations in the profiles were smaller titan the
interindividual var,•tions.
4.2	 Profiles of volatile metabolites in urine of patients with
diabetes mellitus
As described in section'Aspects of Diabetes Mellitus" , a F
variety of abnormalities occurs in the-metabolism of carbohydrates,
lipids and proteins in patients with diabetes.	 The biochemistry of
many of these abnormalities is well known.	 Studying the profiles of
low molecular weight volatile compounds in urine several so far
'	 unknown abnormalities were found.
i
The most characteristic abnormality is the increase in the
j
concentrations of five primary aliphatic alcohols 	 ethanol,
n-propanol, isobutanol, n-butanol and isopentanol. 	 In 80 urine samples
from 31 patients, we found the following results on elevate3 alcohol
z
concentrations:	 ethanol in 90%, n-propanol in 82%, isobutanol in 67%,
u-butanol in 58% and isopentanol in 342 of the cases.
An example of the abnormalities in the profiles of patients
with diabetes mellitus is shown in Figure 2. 	 It is the urine of a
75 year old patient with diabetic retinopathy. 	 The concentrations
of all-five alcohols are increased, especially of ethanol, n-propanol
and isopentanol (peak 3 = ethanol, 6 = n-propanol, 8 = isobutanol,
s
11 = n-butanol, 13 = isopentanol). 	 Using computerized mass (ragmen-
g
tography it is possible to plot selective profiles foi the alcohols.
The fragment ion m/e 31, 1120 - 011, is suitable for profiling the
entire group of primary alcohols (Figure 3). From the spectra of
the repatiti,e scan the computer plots the intensity of this
fragment over the total chromatogram. In Figure 3 the abscissa
indicates the spectrum number of the GC-MS scan. Interference with
detection of primary alcohols occurs only when aldehydes and ketones
are rresent in very high concentration. Even more specificity is
achieved when cdOltional characteristic ions are used. n-Propanol
is detectable r., the molecular ion m/e 60.
With 90% and 82% respectively of the cases studied, ethanol
and n-propanol are most often elevated in uritiL of patients with
diabetes mellitus and appear suitable for screening purposes. Iso-
butanol and isopentanol are less frequently elevated. According to
our findings their concentrations are increased in cases with zom-
plications as described in section 1 (13).
The second characteristic abnormality occurs in the group of
ketones. In the example of Figure 2 the concentration of 4-heptanone
(peak 12) is decreased, of cyclohexanone (peak 15) increased. Selective
r
profiling for the C 7-ketones is possible with the molecular ion m/e
114 (Figure 4) and for cyclohexanone with the molecular ion m/e 90
or the fragment ions m/e 83 and m/e 80 (12).
A dependence of the concentration of cyclohexanone and 4-hepta-
none on severenss and control of diabetes was observed (11,13).
However, the abnormalities in the group of the ketones are much more
differentiated than in the group of the alcohols. The number of
cases investigated so far does not allow the classification of the
findings and the correlations.
Currently we are increasing the number of cases w'.thin
classified groups of diabetics:* infantile, juvenile or adult diabetes
mellitus; insulin deficiency diabetes or insulin resistance diabetes;
presence or absence of complications.
For screening patients in order to detect diabetes the alcohols
may be most useful. Before introducing their detection as a routine
procedure besides blood and urine glucose determinations and glucose
tolerance tests a broad study will be required in order to prove
their significance in diagnozing diabetes. Furthermore it must be
shown that other diseases, e.g. of the pancreas, the liver, or of
the kidneys do not result in similar abnormalities. If this can be
shown profiling the alcohols in urine would be a noninvasive test
which could easily be automated.
TABLE I - COMPOUNDS IN NORMAL URINE
Acetone
2 - butanone
Ethanol
Propionaldehyde
3 - Methyl - 2 - butanone
2,3 - Eutanedione
2,3 - Dimethylfuran
2 - Pentanone
2,4 - Dimethylfuran
Chloroform
4 - Methyl - 2 - pentanone
3 - Methyl - 2 - peptanone
Methyl - ethylfuran
Toluene
Dimethyl disulfide
3 Hexanone
2, 3, 5 - Trimeth lfuran
5 - Methyl - 3 - hexanone
3 - Penten - 2 - one
N - Methylpyrrole
1 - Duranol
4 - Methyl - 3 - penten - 2 - one
4 - Heptanone
2 - Heptanone
3 - Metliylcyclopentanone
6 - Methyl - 3 - hoptanone
3 - Octanone
Methylpyrazine
2 - n - Pentylfuran
2,6 - or 2,5 - Dimethylpyrazine
Allyl isothiocyanate
2,3 - Dimethylpyrazine
Furfural
Vinylpyrazine
2, 3, 5 - Trimethylpyrazine
2 - Methyl - 6 - ethylpyrazine
Pyrrole
2 - Nonanone
Acetylfuran
Benzaldehyde
- Pinene
2 - Methylpyrrole
Diinethylpyrrole
1 - Burylpyrrole
Carvone
Piperitone
p - Cresol
fll
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